Literature DB >> 22886314

Hypoglycemia due to insulin binding antibodies in a patient with insulin-treated type 2 diabetes and Graves' disease.

Xin Wang, Xu-ling Xu, Xiu-li Zhao, Xiao-wen Ma, Hong Yu, Hui Gong, Shi-rong Zhang, Feng-ling Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22886314     DOI: 10.1007/s12020-012-9721-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  3 in total

Review 1.  Insulin autoimmune syndrome (IAS, Hirata disease).

Authors:  Y Uchigata; Y Hirata
Journal:  Ann Med Interne (Paris)       Date:  1999-04

2.  Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone.

Authors:  Rikako Koyama; Koji Nakanishi; Masako Kato; Shigeo Yamashita; Hiroya Kuwahara; Hideyuki Katori
Journal:  Am J Med Sci       Date:  2005-05       Impact factor: 2.378

3.  Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies.

Authors:  Tsuneo Ishizuka; Susumu Ogawa; Takefumi Mori; Kazuhiro Nako; Takashi Nakamichi; Yoshitomo Oka; Sadayoshi Ito
Journal:  Diabetes Res Clin Pract       Date:  2009-03-27       Impact factor: 5.602

  3 in total
  3 in total

Review 1.  Insulin autoimmune syndrome: from diagnosis to clinical management.

Authors:  Simona Censi; Caterina Mian; Corrado Betterle
Journal:  Ann Transl Med       Date:  2018-09

Review 2.  Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.

Authors:  Xiaolei Hu; Fengling Chen
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

3.  Glycemic variation in uncontrolled Graves' disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring.

Authors:  Gu Gao; Feng-Fei Li; Yun Hu; Reng-Na Yan; Bing-Li Liu; Xiao-Mei Liu; Xiao-Fei Su; Jian-Hua Ma; Gang Hu
Journal:  Endocrine       Date:  2018-12-04       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.